From Molecule to Market: How AI Is Reshaping Drug Discovery

About this session

This panel brings together pharma leaders and AI scientists to discuss the evolving drug discovery pipeline. Learn how machine learning is being used to identify new targets, design molecules, and simulate trials—all in less time and at lower cost. Panelists will share what’s working now and what hurdles still exist in AI-driven innovation.